Cihangir Akyol: Adjuvant chemotherapy duration for stage III colon cancer patients with tumor deposits
Cihangir Akyol, Professor of Surgery at Ankara University, shared his recent article on X:
“Thrilled to share our latest publication in the Journal of Gastrointestinal Cancer!
This study reveals game-changing insights on adjuvant chemotherapy duration for stage III colon cancer patients with tumor deposits (pT1-3 / N1c / without LN involvement).
Our findings underscore the powerful impact of a 6-month regimen on improving survival outcomes, marking a step forward in personalized cancer care.”
Authors: Beliz Bahar Karaoğlan, İremsu Öztürk, Cihangir Akyol, Berna Savaş, Güngör Utkan
Immunotherapy for Colon Cancer: Types, Success Rate, Side Effects & More
Dr. Cihangir Akyol is a Professor of Surgery at Ankara University Faculty of Medicine, Ibni Sina Hospital. He holds an international fellowship with the American Society of Colon and Rectal Surgeons and is a member of the European Society of Coloproctology (ESCP). Dr. Akyol serves as a reviewer for the Balkan Medical Journal and the Turkish Journal of Gastroenterology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023